These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17402326)

  • 1. Frontiers of stem cell transplantation monitoring: capturing graft dynamics through routine longitudinal chimerism analysis.
    Kristt D; Stein J; Klein T
    Isr Med Assoc J; 2007 Mar; 9(3):159-62. PubMed ID: 17402326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing quantitative chimerism longitudinally: technical considerations, clinical applications and routine feasibility.
    Kristt D; Stein J; Yaniv I; Klein T
    Bone Marrow Transplant; 2007 Mar; 39(5):255-68. PubMed ID: 17262064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
    Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly sensitive patient-specific real-time PCR SNP assay for chimerism monitoring after allogeneic stem cell transplantation.
    Eshel R; Vainas O; Shpringer M; Naparstek E
    Lab Hematol; 2006; 12(1):39-46. PubMed ID: 16513545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing the method of chimerism monitoring after allogeneic stem cell transplantation using multiplex polymerase chain reaction amplification of short tandem repeat markers and Amelogenin.
    Sufliarska S; Minarik G; Horakova J; Bodova I; Bojtarova E; Czako B; Mistrik M; Drgona L; Demitrovicova M; Lakota J; Krivosikova M; Kovacs L
    Neoplasma; 2007; 54(5):424-30. PubMed ID: 17688372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
    Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A;
    Br J Haematol; 2009 Mar; 144(6):933-45. PubMed ID: 19183198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidic chip-based assay for post-hematopoietic stem cell transplantation chimerism monitoring using polymorphic tandem repeat markers.
    Daud SS; Ibrahim K; Choong SS; Vengidasan L; Chong LA; Ariffin H
    Anal Biochem; 2010 Feb; 397(2):181-5. PubMed ID: 19822126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation and automation of hematopoietic chimerism analysis based on real-time quantitative polymerase chain reaction.
    Masmas TN; Madsen HO; Petersen SL; Ryder LP; Svejgaard A; Alizadeh M; Vindeløv LL
    Biol Blood Marrow Transplant; 2005 Jul; 11(7):558-66. PubMed ID: 15983556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimerism monitoring following allogeneic hematopoietic stem cell transplantation.
    Talwar S; Khan F; Nityanand S; Agrawal S
    Bone Marrow Transplant; 2007 May; 39(9):529-35. PubMed ID: 17334380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of fluorescent in situ hybridization and multiplex short tandem repeat polymerase chain reaction for quantifying chimerism after stem cell transplantation.
    Buño I; Nava P; Simón A; González-Rivera M; Jiménez JL; Balsalobre P; Serrano D; Carrión R; Gómez-Pineda A; Díez-Martín JL
    Haematologica; 2005 Oct; 90(10):1373-9. PubMed ID: 16219574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed chimerism in SCT: conflict or peaceful coexistence?
    Liesveld JL; Rothberg PG
    Bone Marrow Transplant; 2008 Sep; 42(5):297-310. PubMed ID: 18660844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in quantitative chimerism analysis.
    Gineikiene E; Stoskus M; Griskevicius L
    Expert Rev Mol Diagn; 2009 Nov; 9(8):817-32. PubMed ID: 19895227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The kinetics of hematopoietic cell chimerism in the early period after non-myeloablative transplantation and its clinical implications].
    Xiao XB; Sun QY; Guo M; Qiao JH; Yu CL; Ai HS
    Zhonghua Xue Ye Xue Za Zhi; 2004 Aug; 25(8):466-9. PubMed ID: 15555261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of chimerism using a short tandem repeat method on a fluorescent automated DNA sequencer.
    Lobashevsky AL; Senkbeil RW; Townsend JE; Mink CA; Thomas JM
    Clin Lab Haematol; 2006 Feb; 28(1):40-9. PubMed ID: 16430459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemopoietic chimerism following stem cell transplantation.
    McCann SR; Crampe M; Molloy K; Lawler M
    Transfus Apher Sci; 2005 Feb; 32(1):55-61. PubMed ID: 15737874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A SYBR green-based real-time PCR method for detection of haemopoietic chimerism in allogeneic haemopoietic stem cell transplant recipients.
    Bai L; Deng YM; Dodds AJ; Milliken S; Moore J; Ma DD
    Eur J Haematol; 2006 Nov; 77(5):425-31. PubMed ID: 16899058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transplant monitoring of chimerism by lineage-specific analysis.
    Preuner S; Lion T
    Methods Mol Biol; 2014; 1109():271-91. PubMed ID: 24473788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma.
    Kröger N; Zagrivnaja M; Schwartz S; Badbaran A; Zabelina T; Lioznov M; Ayuk F; Zander A; Fehse B
    Exp Hematol; 2006 May; 34(5):688-94. PubMed ID: 16647575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders.
    Ozyurek E; Cowan MJ; Koerper MA; Baxter-Lowe LA; Dvorak CC; Horn BN
    Bone Marrow Transplant; 2008 Jul; 42(2):83-91. PubMed ID: 18391990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.